September
Pompe drug wins orphan status
The US Food and Drug Administration has granted orphan drug status to BioMarin Pharmaceutical's investigational therapy for Pompe disease
01 Sep 2010
GSK epilepsy drug delayed
The US Food and Drug Administration has delayed the decision date of the marketing application for GSK's experimental epilepsy drug ezogabine
01 Sep 2010
UK's EMIG set to join EUCOPE
The EMIG Steering Group has obtained approved membership of EUCOPE
01 Sep 2010
Prism Ideas appoints Nigel Brooksby
Medical communications and drug development consultancy, Prism Ideas, has appointed Nigel Brooksby as non-executive chairman
01 Sep 2010
Pfizer to acquire FoldRx Pharma
Pfizer has announced it is to acquire FoldRx Pharmaceuticals, a privately held drug discovery and clinical development company
01 Sep 2010
Takeda enters partnership over Contrave
Takeda and Orexigen have entered into a partnership to commercialise investigational obesity drug Contrave in North America
02 Sep 2010
European MDD approval for Seroquel XR
The European Commission has approved AstraZeneca's Seroquel XR as an add-on treatment for major depressive disorder
02 Sep 2010
EC approves PecFent for cancer pain
The European Commission has granted Archimedes Pharma marketing authorisation for PecFent, a nasal spray for breakthrough cancer pain in adults
02 Sep 2010
Lilly Evista patents upheld
Eli Lilly has won a court victory that the company said will keep osteoporosis drug Evista protected from generic competition in the US until 2014
02 Sep 2010
Increased risk of death linked with Tygacil
The US FDA has issued a safety warning to remind healthcare professionals of the increased mortality risk associated with antibacterial Tygacil
02 Sep 2010